MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
SAR
Saratoga Investment Corp.
There isn't enough reported data to score SAR yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
SAR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
SAR's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like SAR.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
SAR PE Valuation
SAR has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over SAR on the outlook, with more favorable earnings and profitability expectations.
SAR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect SAR's revenue to grow, but its earnings and profitability to decline. However, they disagree widely on these estimates.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over SAR on earnings quality, reporting a profit while its opponent remains loss making.
SAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.02 | — |
| Q3 2026 | -$0.27 | -112% |
| Q2 2026 | $0.98 | -60% |
| Q1 2026 | $2.31 | +14% |
| Q4 2025 | $2.42 | -2.4% |
| Q3 2025 | $2.32 | +52% |
| Q2 2025 | $2.45 | +102% |
| Q1 2025 | $2.02 | +185% |
| Q4 2022 | $1.17 | -72% |
SAR has swung to a loss: it lost $0.27 per share over the past year, after a profit the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the stronger quarterly revenue trend. Revenue is up 12% for MS versus down 35% for SAR.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
SAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $11.8M | -35% |
| Q2 2022 | $7.6M | -72% |
| Q1 2022 | $16.6M | +0.8% |
| Q4 2021 | $15M | -4% |
| Q3 2021 | $18.3M | -31% |
| Q1 2021 | $16.5M | -50% |
SAR's revenue has slid since its 2020 peak: $12M last quarter, down 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | 9.1% | -44 points |
| Q2 2022 | -17% | -94 points |
| Q1 2022 | 55% | -8 points |
| Q4 2021 | 55% | -12 points |
| Q3 2021 | 53% | -29 points |
| Q2 2021 | 77% | N/A |
| Q1 2021 | 63% | N/A |
| Q4 2020 | 67% | -15 points |
SAR's operating margin was 9.1% last quarter, down 44 points from the same quarter a year ago, near the bottom of its range since 2020.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over SAR on cash flow, with more consistent year-over-year improvement.
SAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$27.8M | -$8.5M |
| Q2 2026 | -$26M | -180% |
| Q1 2026 | -$92.4M | -$72.5M |
| Q4 2025 | -$8.6M | -109% |
| Q3 2025 | -$19.3M | -127% |
| Q2 2025 | $32.3M | -38% |
| Q1 2025 | -$19.9M | +$741.4K |
| Q4 2024 | $94.2M | +$112.7M |
SAR's free cash flow was −$155M over the past year, against $87M the year before. Free cash flow isn't a meaningful measure for financial services companies like SAR.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over SAR on shareholder dilution, with a more favorable share count trend.
SAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -97.3K shares |
| 1 year | +2.4% | +380K shares |
| 3 years | +33% | +4M shares |
| 5 years | +45% | +5M shares |
| Available history | +44% | +5M shares |
SAR has 16M diluted shares, up 2.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $2.2M |
| Q1 2023 | $1.2M |
| Q4 2022 | $2.2M |
| Q3 2022 | $3.7M |
| Q2 2022 | $3.7M |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
SAR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 35.8x | High |
| Q2 2022 | 20.9x | High |
| Q1 2022 | 9.3x | High |
| Q4 2021 | 6.6x | High |
| Q3 2021 | 6.6x | High |
| Q2 2021 | 5.8x | High |
| Q1 2020 | 3.2x | Elevated |
SAR's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SAR.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
SAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.3 | Oversold |
| Stochastic | 3.6 | Oversold |
SAR's weekly RSI is 19 (oversold) and its Stochastic is 4 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over SAR on valuation relative to its sector.
SAR PE vs Financial Services Sector
| Metric | SAR | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 29% above |
| PE % | 77 | 63 | 14 pts above |
SAR has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over SAR on trend strength, trading above more of its moving averages.
SAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.5 | 19% below |
| 20 week MA | $17.1 | 32% below |
| 50 week MA | $20.5 | 43% below |
| 100 week MA | $22.4 | 48% below |
| 200 week MA | $23.5 | 50% below |
SAR is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over SAR on returns for 2026, with the stronger performance.
SAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.0 | $20.7 | -17% |
| 2021 | $20.7 | $29.3 | +42% |
| 2022 | $29.3 | $25.6 | -13% |
| 2023 | $25.6 | $25.9 | +1.1% |
| 2024 | $25.9 | $23.8 | -8.1% |
| 2025 | $23.8 | $23.2 | -2.5% |
| 2026 YTD | $23.2 | $11.7 | -50% |
SAR has finished lower in four of the last six years. It's down 50% so far in 2026.